Announcement on Resignation of Director
Filed with SSE · · 1 page · Chinese
Jiangsu Cowin Biotech Co., Ltd. on 6ix
Earlier from Jiangsu Cowin Biotech
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
- Announcement on Opening Special Account for Raised Funds and Signing Four-party Supervision Agreement for Raised Funds by New Entity of Investment Projects Financed by Raised Funds
- Announcement on Convening the Q3 2024 Performance Briefing
- Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Novel Coronavirus Nucleic Acid Detection Kit
- Announcement on Listing and Circulation of Partial Restricted Stocks for Strategic Placement in Initial Public Offering
Later from Jiangsu Cowin Biotech
- Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Helicobacter Pylori Resistance Gene Test Kit
- Announcement on Cancellation of Share Options Not Exercised at the End of the 2nd Exercise Period and Failing to Meet Exercise Conditions in the 3rd Exercise Period of the 2021 Stock Option Incentive Plan
- Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
- Announcement on Resignation of Deputy General Manager and Chief Financial Officer
- Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Detection Kit
Follow Jiangsu Cowin Biotech into a list and get an email when it puts out news.
Follow Jiangsu Cowin Biotech